UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
A A A+ A- A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 AA AB AC AD AE AF AG AH AI AJ AK AL AM AN AO AP AQ AR AS AT AU AV AW AX AY AZ
selected terms: 8,142 page 51 of 82

5001. ANAL OPERATION NEC
[ ] (UMLS (ICD9CM) C0176874) =Therapeutic or Preventive Procedure
5051. Anaphylactic shock due to adverse food reaction to other specified food
[ ] (UMLS (ICD9CM) C0375712) =Injury or Poisoning
5002. ANAL OR RECTAL PAIN
(UMLS (ICD9CM) C0002758) =Sign or Symptom
5052. Anaphylactic shock due to adverse food reaction to peanuts
[ ] (UMLS (ICD9CM) C0375704) =Injury or Poisoning
5003. Anal Paget's Disease
[A slowly spreading, erythematous eczematoid plaque in the anal region. Histologically, the basal part or whole thickness of the squamous epithelium is infiltrated by large cells with abundant pale cytoplasm and large nuclei. Half of the cases are associated with an internal malignancy, most often a colorectal adenocarcinoma. The other half of the cases, have a high local recurrence rate and they may become invasive (WHO). ( NCI )] (UMLS (NCI) C1332274) Paget Disease of the Anus;
Paget's Disease of Anus;
Paget's Disease of the Anus =Neoplastic Process
5053. Anaphylactic shock due to adverse food reaction to tree nuts and seeds
[ ] (UMLS (ICD9CM) C0375707) =Injury or Poisoning
5004. Anal Pit
(UMLS (NCI) C0231054) =Embryonic Structure
5054. Anaphylactic shock due to serum, not elsewhere classified
[ ] (UMLS (ICD9CM) C0728865) ANAPHYLACTIC SHOCK-SERUM =Disease or Syndrome ;
5005. Anal Polyp
[This is a descriptive term referring of a mass of tissue that bulges or projects into the lumen of the anal lumen. The mass is macroscopically visible and may either have a broad base attachment to the rectal wall, or be on a pedunculated stalk. These may be benign or malignant. ( NCI )] (UMLS (NCI) C0267573) =Neoplastic Process ;
5055. Anaphylactic shock due to unspecified food
[ ] (UMLS (ICD9CM) C0375703) =Injury or Poisoning
5006. Anal Precancerous Condition
(UMLS (NCI) C1332275) Anal Premalignant Condition =Disease or Syndrome
5056. anaphylatoxin
[complement peptides (C3a and C5a) which cause mast cell degranulation and smooth muscle contraction. ( CSP )] (UMLS (CSP) C0220783) =Amino Acid, Peptide, or Protein; Biologically Active Substance; Hazardous or Poisonous Substance =blood protein;
5007. Anal Region
(UMLS (NCI) C1275631) =Body Location or Region
5057. Anaplasia
[Loss of structural differentiation and useful function of neoplastic cells. ( MSH )] (UMLS (NCI) C0002793) =Neoplastic Process
5008. Anal Rhabdomyosarcoma
[A malignant mesenchymal tumor with skeletal muscle differentiation affecting the anus. ( NCI )] (UMLS (NCI) C1332276) Rhabdomyosarcoma of Anus;
Rhabdomyosarcoma of the Anus;
=Neoplastic Process
5058. Anaplasma
[A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis. ( MSH )] (UMLS (CSP) C0002794) =Rickettsia or Chlamydia
5009. Anal Sarcoma
[A malignant mesenchymal neoplasm arising from the anus. Representative examples include leiomyosarcoma, rhabdomyosarcoma, and Kaposi sarcoma. ( NCI )] (UMLS (NCI) C1332277) Sarcoma of Anus;
Sarcoma of the Anus;
=Neoplastic Process
5059. anaplastic
[(an-ah-PLAS-tik) A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells. ( NCI )] (UMLS (NCI) C0205618) =Qualitative Concept
5010. Anal Sinus
(UMLS (NCI) C0227427) =Body Space or Junction
5060. Anaplastic (Malignant) Intracranial Meningioma
(UMLS (NCI) C1332285) =Neoplastic Process
5011. ANAL SPASM
(UMLS (ICD9CM) C0152167) =Disease or Syndrome
5061. Anaplastic (Malignant) Intraspinal Meningioma
[Abnormal malignant growth of the tissues that comprise the spinal meninges: pia, arachnoid, dura. ( NCI )] (UMLS (NCI) C1332286) Anaplastic Intraspinal Meningioma;
Malignant Intraspinal Meningioma;
Malignant Meningioma of Spinal Canal and Spinal Cord;
Malignant Meningioma of the Spinal Canal and Spinal Cord;
Malignant Spinal Canal and Spinal Cord Meningioma =Neoplastic Process
5012. ANAL SPHINCT REPAIR NEC
[ ] (UMLS (ICD9CM) C0176873) =Therapeutic or Preventive Procedure
5062. Anaplastic (Malignant) Meningioma
[A rare, quickly growing tumor that occurs in the membranes that cover and protect the brain and spinal cord (meninges). ( NCI )] (UMLS (NCI) C0259785) =Neoplastic Process
5013. Anal sphincter tear (healed) (old)
[ ] (UMLS (ICD9CM) C1955814) ANAL SPHINCTER TEAR-OLD;
=Disease or Syndrome ;
5063. Anaplastic Astrocytoma
[A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO) ( NCI )] (UMLS (NCI) C0334579) =Neoplastic Process
5014. Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration
[ ] (UMLS (ICD9CM) C1955493) =Disease or Syndrome
5064. Anaplastic Astrocytoma of Cerebral Hemisphere
(UMLS (NCI) C1332282) Anaplastic Astrocytoma of the Cerebral Hemisphere;
Anaplastic Astrocytoma, Hemispheric;
Anaplastic Hemispheric Astrocytoma;
Cerebral Hemisphere Anaplastic Astrocytoma;
Grade III Astrocytic Neoplasm of Cerebral Hemisphere;
Grade III Astrocytic Neoplasm of the Cerebral Hemisphere;
Grade III Astrocytic Tumor of Cerebral Hemisphere;
Grade III Astrocytic Tumor of the Cerebral Hemisphere;
Grade III Astrocytoma of Cerebral Hemisphere;
Grade III Astrocytoma of the Cerebral Hemisphere;
Grade III Cerebral Hemisphere Astrocytic Neoplasm;
Grade III Cerebral Hemisphere Astrocytic Tumor;
Grade III Cerebral Hemisphere Astrocytoma;
Grade III Hemispheric Astrocytic Neoplasm;
Grade III Hemispheric Astrocytic Tumor;
Grade III Hemispheric Astrocytoma;
Hemispheric Anaplastic Astrocytoma;
Undifferentiated Astrocytoma of Cerebral Hemisphere;
Undifferentiated Astrocytoma of the Cerebral Hemisphere =Neoplastic Process
5015. Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, postpartum
[ ] (UMLS (ICD9CM) C1955492) ANAL SPHINCTR TEAR W P/P;
=Disease or Syndrome
5065. Anaplastic Astrocytoma of Diencephalon
(UMLS (NCI) C1332281) Anaplastic Astrocytoma of the Diencephalon;
Anaplastic Diencephalic Astrocytoma;
Diencephalic Anaplastic Astrocytoma;
Grade III Astrocytic Neoplasm of Diencephalon;
Grade III Astrocytic Neoplasm of the Diencephalon;
Grade III Astrocytic Tumor of Diencephalon;
Grade III Astrocytic Tumor of the Diencephalon;
Grade III Astrocytoma of Diencephalon;
Grade III Astrocytoma of the Diencephalon;
Grade III Diencephalic Astrocytic Neoplasm;
Grade III Diencephalic Astrocytic Tumor;
Grade III Diencephalic Astrocytoma;
Undifferentiated Astrocytoma of Diencephalon;
Undifferentiated Astrocytoma of the Diencephalon;
Undifferentiated Diencephalic Astrocytoma =Neoplastic Process
5016. Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, unspecified as to episode of care
[ ] (UMLS (ICD9CM) C1955490) ANAL SPHINCTER TEAR NOS;
=Disease or Syndrome ;
5066. Anaplastic Brain Stem Astrocytoma
(UMLS (NCI) C1332279) Anaplastic Brainstem Astrocytoma =Neoplastic Process
5017. Anal sphincter tear complicating delivery, not associated with third-degree perineal laceration, with delivery
[ ] (UMLS (ICD9CM) C1955491) ANAL SPHINCTER TEAR-DEL;
=Disease or Syndrome ;
5067. Anaplastic Brain Stem Glioma
(UMLS (NCI) C1332280) Anaplastic Brainstem Glioma;
Anaplastic Glioma of Brain Stem;
Anaplastic Glioma of Brainstem;
Anaplastic Glioma of the Brain Stem;
Anaplastic Glioma of the Brainstem;
Brain Stem Glioma, Grade III;
Brainstem Glioma, Grade III;
Grade III Brain Stem Glioma;
Grade III Brainstem Glioma;
Grade III Glioma of Brain Stem;
Grade III Glioma of Brainstem;
Grade III Glioma of the Brain Stem;
Grade III Glioma of the Brainstem;
Undifferentiated Brain Stem Glioma;
Undifferentiated Brainstem Glioma;
Undifferentiated Glioma of Brain Stem;
Undifferentiated Glioma of Brainstem;
Undifferentiated Glioma of the Brain Stem;
Undifferentiated Glioma of the Brainstem =Neoplastic Process
5018. ANAL SPHINCTEROTOMY NEC
[ ] (UMLS (ICD9CM) C0176871) =Therapeutic or Preventive Procedure
5068. Anaplastic Carcinoma
[A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation. ( NCI )] (UMLS (NCI) C0205698) =Neoplastic Process ;
5019. Anal Squamous Cell Carcinoma
[A squamous cell carcinoma (SCC) arising from the anal canal or the anal margin (perianal skin). Human papilloma virus is detected in the majority of cases. Homosexual HIV-positive men have an increased risk of developing anal squamous cell carcinoma in comparison to the general male population. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. The prognosis is generally better for anal margin SCC than for anal canal SCC. ( NCI )] (UMLS (NCI) C1412036) Epidermoid Anal Carcinoma;
Epidermoid Carcinoma of Anus;
Epidermoid Carcinoma of the Anus;
Squamous Cell Anal Carcinoma;
Squamous Cell Carcinoma of Anus;
Squamous Cell Carcinoma of the Anus =Neoplastic Process ;
5069. Anaplastic Carcinoma of Extrahepatic Bile Duct
(UMLS (NCI) C1336856) Anaplastic Carcinoma of the Extrahepatic Bile Duct;
Anaplastic Extrahepatic Bile Duct Carcinoma;
Undifferentiated Carcinoma of Extrahepatic Bile Duct;
Undifferentiated Carcinoma of the Extrahepatic Bile Duct;
Undifferentiated Extrahepatic Bile Duct Carcinoma =Neoplastic Process ;
5020. Anal Verge
[The transitional zone between the moist, hairless, modified skin of the anal canal and the perianal skin. ( NCI )] (UMLS (NCI) C0227423) =Body Part, Organ, or Organ Component
5070. Anaplastic Carcinoma of Gallbladder
(UMLS (NCI) C0279653) =Neoplastic Process
5021. ANAL/PERIAN DX PROC NEC
[ ] (UMLS (ICD9CM) C0176863) =Diagnostic Procedure
5071. Anaplastic Carcinoma of Minor Salivary Gland
(UMLS (NCI) C1334775) Anaplastic Carcinoma of the Minor Salivary Gland;
Anaplastic Minor Salivary Gland Carcinoma;
Minor Salivary Gland Undifferentiated Carcinoma;
Undifferentiated Carcinoma of Minor Salivary Gland;
Undifferentiated Carcinoma of the Minor Salivary Gland;
=Neoplastic Process ;
5022. analeptic
[ ] (UMLS (CSP) C0242181) =Pharmacologic Substance
5072. Anaplastic Carcinoma of Ovary
(UMLS (NCI) C0346167) =Neoplastic Process
5023. analgesia
[absence of sensibility to pain; relief of pain without the loss of consciousness. ( CSP )] (UMLS (CSP) C0002766) =Therapeutic or Preventive Procedure
5073. Anaplastic Carcinoma of Parotid
(UMLS (NCI) C1336862) Anaplastic Carcinoma of Parotid Gland;
Anaplastic Carcinoma of the Parotid;
Anaplastic Carcinoma of the Parotid Gland;
Anaplastic Parotid Carcinoma;
Anaplastic Parotid Gland Carcinoma;
Parotid Gland Undifferentiated Carcinoma;
Undifferentiated Carcinoma of Parotid;
Undifferentiated Carcinoma of Parotid Gland;
Undifferentiated Carcinoma of the Parotid;
Undifferentiated Carcinoma of the Parotid Gland;
Undifferentiated Parotid Gland Carcinoma =Neoplastic Process
5024. Analgesic and Antipyretic
[Nonnarcotic agents that relieve pain and reduce fever. ( NCI )] (UMLS (NCI) C0280004) =Pharmacologic Substance
5074. Anaplastic Carcinoma of Rectum
(UMLS (NCI) C1336864) Anaplastic Carcinoma of the Rectum;
Rectal Anaplastic Carcinoma;
Rectal Undifferentiated Carcinoma;
Undifferentiated Carcinoma of Rectum;
Undifferentiated Carcinoma of the Rectum;
Undifferentiated Rectal Carcinoma;
=Neoplastic Process
5025. Analgesic Management
[A health/illness/pain management principle specifically directed at the management of pharmacologic agents in maximizing beneficial outcomes and minimizing unfavorable effects. ( NCI )] (UMLS (NCI) C0150270) =Health Care Activity
5075. Anaplastic Carcinoma of Salivary Gland
(UMLS (NCI) C0279749) =Neoplastic Process
5026. Analgesics, antipyretics, and antirheumatics causing adverse effects in therapeutic use
[ ] (UMLS (ICD9CM) C0261814) =Injury or Poisoning
5076. Anaplastic Carcinoma of Stomach
(UMLS (NCI) C1336858) Anaplastic Carcinoma of the Stomach;
Anaplastic Gastric Carcinoma;
Undifferentiated Carcinoma of Stomach;
Undifferentiated Carcinoma of the Stomach;
Undifferentiated Gastric Carcinoma =Neoplastic Process ;
5027. analog
[general term for synthetic or natural chemical compounds which resemble naturally occurring compounds in structure and/or function. ( CSP )] (UMLS (NCI) C0243071) =Chemical Viewed Structurally ;
=Chemical;
=coenzyme;
hormone analog;
aminoacid analog;
benzimidazole analog;
carbohydrate analog;
enzyme substrate analog;
fatty acid analog;
glucose analog;
methotrexate analog;
nucleobase analog;
nucleotide analog;
peptide analog;
pteridine analog;
quinoline analog;
steroid analog;
vitamin analog;
nucleoside analog;
5077. Anaplastic Carcinoma of Submandibular Gland
(UMLS (NCI) C1336526) Anaplastic Carcinoma of the Submandibular Gland;
Submandibular Gland Undifferentiated Carcinoma;
Undifferentiated Carcinoma of Submandibular Gland;
Undifferentiated Carcinoma of the Submandibular Gland;
=Neoplastic Process ;
5028. Analysis
[Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it. ( NCI )] (UMLS (NCI) C0936012) Analytical;
Analyzed;
=Research Activity
5078. Anaplastic Carcinoma of the Thyroid
[(an-a-PLAS-tik) A rare, aggressive type of thyroid cancer in which the malignant (cancer) cells look very different from normal thyroid cells. ( NCI )] (UMLS (NCI) C0238461) =Neoplastic Process
5029. Analysis of Variance
[A statistical technique which helps in making inference whether three or more samples might come from populations having the same mean; specifically, whether the differences among the samples might be caused by chance variation. ( NCI )] (UMLS (NCI) C0002780) =Quantitative Concept
5079. Anaplastic Carcinoma of the Ureter
(UMLS (NCI) C1336866) Anaplastic Carcinoma of Ureter;
Anaplastic Ureter Carcinoma;
Anaplastic Ureteral Carcinoma;
Undifferentiated Carcinoma of the Ureter;
Undifferentiated Carcinoma of Ureter;
Undifferentiated Ureter Carcinoma;
Undifferentiated Ureteral Carcinoma =Neoplastic Process
5030. Analyte repeat status
(UMLS (HL7) C1547781) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Repeated with dilution;
Reflex test;
Original, first run;
Repeated without dilution;
5080. Anaplastic Carcinoma of the Urethra
(UMLS (NCI) C1336867) Anaplastic Carcinoma of Urethra;
Anaplastic Urethra Carcinoma;
Anaplastic Urethral Carcinoma;
Undifferentiated Carcinoma of the Urethra;
Undifferentiated Carcinoma of Urethra;
Undifferentiated Urethra Carcinoma;
Undifferentiated Urethral Carcinoma =Neoplastic Process
5031. analytical chemistry
[branch of chemistry dealing with detection (qualitative) and determination (quantitative) of substances. ( CSP )] (UMLS (CSP) C0007998) =Occupation or Discipline ;
=chemistry;
5081. Anaplastic Central Nervous System Large Cell Lymphoma
(UMLS (NCI) C1335476) Anaplastic CNS Large Cell Lymphoma;
Anaplastic Large Cell Lymphoma of Central Nervous System;
Anaplastic Large Cell Lymphoma of CNS;
Anaplastic Large Cell Lymphoma of the Central Nervous System;
Anaplastic Large Cell Lymphoma of the CNS;
Central Nervous System Anaplastic Large Cell Lymphoma;
Primary Central Nervous System Anaplastic Large Cell Lymphoma;
Primary CNS Anaplastic Large Cell Lymphoma =Neoplastic Process ;
5032. analytical method
[systematic procedure or technique used to break down material into its component parts so that its organizational structure may be understood; determination of the chemical and/or physical composition of a substance, or mixture of components. ( CSP )] (UMLS (CSP) C0178476) =Intellectual Product =technology/technique;
=activation analysis;
affinity labeling;
Crystallography, X-Ray Diffraction;
spectrometry;
chemical fingerprinting;
neutron diffraction;
physical separation;
temperature jump;
nucleic acid quantitation/detection;
protein quantitation/detection
5082. Anaplastic Childhood Astrocytoma
(UMLS (NCI) C0280474) =Neoplastic Process ;
5033. analytical ultracentrifugation
[centrifuge optimized for spinning a rotor at very high speeds, capable of generating G forces and equipped with an optical detection system that allows the operator to observe the sample concentration in real time during the experiment; the kinds of information that can be discerned from a good analytical ultracentrifuge include the shape, conformational changes, subunit stoichiometry, approximate molecular weights, and equilibrium constants for macromolecules. ( CSP )] (UMLS (CSP) C0596085) =Laboratory Procedure ;
=ultracentrifugation;
5083. Anaplastic Childhood Astrocytoma of Brain
(UMLS (NCI) C1332947) Anaplastic Childhood Astrocytoma of the Brain;
Anaplastic Childhood Brain Astrocytoma;
Anaplastic Pediatric Astrocytoma of Brain;
Anaplastic Pediatric Astrocytoma of the Brain;
Anaplastic Pediatric Brain Astrocytoma;
Childhood Brain Anaplastic Astrocytoma;
Grade III Childhood Astrocytic Neoplasm of Brain;
Grade III Childhood Astrocytic Neoplasm of the Brain;
Grade III Childhood Astrocytic Tumor of Brain;
Grade III Childhood Astrocytic Tumor of the Brain;
Grade III Childhood Astrocytoma of Brain;
Grade III Childhood Astrocytoma of the Brain;
Grade III Childhood Brain Astrocytic Neoplasm;
Grade III Childhood Brain Astrocytic Tumor;
Grade III Childhood Brain Astrocytoma;
Grade III Pediatric Astrocytic Neoplasm of Brain;
Grade III Pediatric Astrocytic Neoplasm of the Brain;
Grade III Pediatric Astrocytic Tumor of Brain;
Grade III Pediatric Astrocytic Tumor of the Brain;
Grade III Pediatric Astrocytoma of Brain;
Grade III Pediatric Astrocytoma of the Brain;
Grade III Pediatric Brain Astrocytic Neoplasm;
Grade III Pediatric Brain Astrocytic Tumor;
Grade III Pediatric Brain Astrocytoma =Neoplastic Process
5034. anamnestic reaction
[altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. ( CSP )] (UMLS (CSP) C0021055) =Organ or Tissue Function ;
=immunity;
anamnestic reaction;
immune modulation;
=anamnestic reaction
5084. Anaplastic Childhood Oligodendroglioma
(UMLS (NCI) C1332943) Anaplastic Pediatric Oligodendroglioma;
Childhood Anaplastic Oligodendroglioma;
Undifferentiated Childhood Oligodendroglioma;
Undifferentiated Pediatric Oligodendroglioma =Neoplastic Process
5035. ANAN/BSRL
(UMLS (NCI) C0677835) =Therapeutic or Preventive Procedure ;
5085. Anaplastic Choroid Plexus Papilloma
[A rare type of cancer that occurs in the ventricles of the brain. It usually occurs in children younger than 2 years. ( NCI )] (UMLS (NCI) C0085138) =Neoplastic Process ;
=Brain Neoplasms, Intraventricular;
=Choroid Plexus Papilloma
5036. ANAN/LEUP
(UMLS (NCI) C0677837) =Therapeutic or Preventive Procedure ;
5086. Anaplastic Choroid Plexus Papilloma
[A malignant neoplasm arising from the Choroid Plexus. It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0431109) =Neoplastic Process
5037. ANAN/ZDX
(UMLS (NCI) C0278890) =Therapeutic or Preventive Procedure
5087. Anaplastic Diffuse Large B-Cell Lymphoma PTLD
(UMLS (NCI) C1332284) Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder;
Anaplastic Lymphoma PTLD;
=Neoplastic Process
5038. anandamide
[endogenous compound produced in the brain and possibly other organs, which binds to one of the most ubiquitous receptors in the brain, the delta9- tetrahydrocannabinol receptor. ( CSP )] (UMLS (CSP) C0211726) =Eicosanoid; Biologically Active Substance ;
=arachidonate;
endocannabinoid
5088. Anaplastic Ependymal Neoplasm
[A malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0280788) =Neoplastic Process
5039. Anandron
(UMLS (NCI) C0740136) =Organic Chemical; Pharmacologic Substance ;
5089. Anaplastic Ganglioglioma
[A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0431112) =Neoplastic Process
5040. anaphase
[Progression through anaphase, the third stage of chromosome segregation in the cell cycle. Canonically, sister chromatids (or homologous chromosomes) separate and migrate towards the poles of the spindle. [http://www.onelook.com] ( GO )] (UMLS (CSP) C1622911) =Cell Function ;
5090. Anaplastic Giant Cell Carcinoma of the Thyroid
[A morphologic variant of undifferentiated (anaplastic) carcinoma of the thyroid gland, characterized by the presence of large numbers of non-neoplastic, osteoclast-like giant cells. (NCI05) ( NCI )] (UMLS (NCI) C0278859) =Neoplastic Process
5041. Anaphase
[The third phase of mitosis during which the two groups of daughter chromosomes separate and move along the fibers of the central spindle, each toward one of the asters, forming the diaster. ( NCI )] (UMLS (NCI) C0002788) =Cell Function
5091. Anaplastic Large B-Cell Lymphoma
(UMLS (NCI) C1321546) Anaplastic Lymphoma =Neoplastic Process ;
5042. Anaphylactic Reaction
[a manifestation of immediate hypersensitivity in which exposure of a sensitized individual to a specific antigen or hapten results in urticaria, pruritis and angioedema, followed by vascular collapse and shock often accompanied by life threatening respiratory distress. ( CSP )] (UMLS (HL7) C0002792) =Pathologic Function
5092. Anaplastic large cell lymphoma involving intra-abdominal lymph nodes
[ ] (UMLS (ICD9CM) C1955712) ANAPLASTIC LYMPH ABDOM;
=Neoplastic Process
5043. ANAPHYLACTIC SHOCK
[ ] (UMLS (ICD9CM) C0375697) =Pathologic Function
5093. Anaplastic large cell lymphoma involving intrapelvic lymph nodes
[ ] (UMLS (ICD9CM) C1955715) ANAPLASTIC LYMPH PELVIC;
=Neoplastic Process
5044. Anaphylactic shock due to adverse food reaction
(UMLS (ICD9CM) C0685898) =Injury or Poisoning
5094. Anaplastic large cell lymphoma involving intrathoracic lymph nodes
[ ] (UMLS (ICD9CM) C1955711) ANAPLASTIC LYMPH THORAX;
=Neoplastic Process
5045. Anaphylactic shock due to adverse food reaction to crustaceans
[ ] (UMLS (ICD9CM) C0375705) =Injury or Poisoning
5095. Anaplastic large cell lymphoma involving lymph nodes of axilla and upper limb
[ ] (UMLS (ICD9CM) C1955713) ANAPLASTIC LYMPH AXILLA;
=Neoplastic Process
5046. Anaphylactic shock due to adverse food reaction to eggs
[ ] (UMLS (ICD9CM) C0375711) =Injury or Poisoning
5096. Anaplastic large cell lymphoma involving lymph nodes of head, face, and neck
[ ] (UMLS (ICD9CM) C1955710) ANAPLASTIC LYMPH HEAD;
=Neoplastic Process
5047. Anaphylactic shock due to adverse food reaction to fish
[ ] (UMLS (ICD9CM) C0375708) =Injury or Poisoning
5097. Anaplastic large cell lymphoma involving lymph nodes of inguinal region and lower limb
[ ] (UMLS (ICD9CM) C1955714) ANAPLASTIC LYMPH INGUIN;
=Neoplastic Process
5048. Anaphylactic shock due to adverse food reaction to food additives
[ ] (UMLS (ICD9CM) C0375709) =Injury or Poisoning
5098. Anaplastic large cell lymphoma involving lymph nodes of multiple sites
[ ] (UMLS (ICD9CM) C1955717) ANAPLASTIC LYMPH MULTIP;
=Neoplastic Process
5049. Anaphylactic shock due to adverse food reaction to fruits and vegetables
[ ] (UMLS (ICD9CM) C0375706) =Injury or Poisoning
5099. Anaplastic large cell lymphoma involving spleen
[ ] (UMLS (ICD9CM) C1955716) ANAPLASTIC LYMPH SPLEEN;
=Neoplastic Process
5050. Anaphylactic shock due to adverse food reaction to milk products
[ ] (UMLS (ICD9CM) C0375710) =Injury or Poisoning
5100. Anaplastic Large Cell Lymphoma Stage I
[Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).- 2003 ( NCI )] (UMLS (NCI) C0854822) Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage I;
Stage I Anaplastic Large Cell Lymphoma;
=Neoplastic Process


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM